BFM
NEO icon

Boothbay Fund Management’s NeoGenomics NEO Stock Holding History

Boothbay Fund Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,952
Closed -$368K – 1784
2024
Q3 		$368K Buy
+24,952
New +$390K 0.01% 1122
2022
Q3 		– Sell
-28,323
Closed -$231K – 2480
2022
Q2 		$231K Buy
+28,323
New +$270K 0.01% 1638

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Boothbay Fund Management's NEO Position: Q4 2024 in Review

Boothbay Fund Management sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 24,952 shares — an estimated $368K sold.

Boothbay Fund Management first reported a position in NEO in Q2 2022 and held it in 2 quarters. The position peaked at $368K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

  • Boothbay Fund Management reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 24,952 NeoGenomics shares in Q4 2024, an estimated $368K.
  • Boothbay Fund Management first reported a position in NeoGenomics in Q2 2022 and held it in 2 quarters.
  • Boothbay Fund Management's NeoGenomics position peaked at $368K in Q3 2024.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.